Buy the dip NOW on one ASX lithium stock with 6.5% yield, and these healthcare shares

Experts reckon heavy discounting makes these investments no-brainer buys.

| More on:
A man scoots in superman pose across a bride, excited about a future with electric vehicles.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sometimes excellent companies present eye-opening buy-the-dip opportunities.

That's because share prices are a reflection of market sentiment — which includes fear and greed — not necessarily business performance.

Humans act irrationally, including stock investors.

So here is a pair of ASX shares shunned by the market in recent weeks that experts are tipping as golden buying opportunities right now:

The lithium miner that will 'deliver'

If you ever wanted to get a piece of the lithium action, this could be your chance.

That's because global prices for the mineral are down this year due to weak Chinese demand, and consequently weakening the valuations of lithium miners. However, many analysts reckon in the long run, the world will only want more of the good stuff for a low-carbon future.

One of the bigger producers, Pilbara Minerals Ltd (ASX: PLS), has seen its stock price plunge more than 28% since 10 August.

Medallion Financial Group director Philippe Bui reckons Pilbara will end up an outstanding investment once lithium prices normalise.

"Pilbara is trading on an undemanding price/earnings ratio," Bui told The Bull.

"The company aims to produce a million tonnes by the end of 2025, a significant increase on existing production."

Pilbara Minerals also has plenty of money in the bank while paying a fully franked 6.5% dividend yield.

"The company paid a fully franked full-year dividend of 25 cents a share in fiscal year 2023," said Bui.

"The lithium company had $3.3 billion of cash on its balance sheet when announcing its full-year results… Provided lithium prices settle in what has been a recent downturn, Pilbara should be able to deliver."

Time to buy the dip on a much-discussed ASX stock

Resmed CDI (ASX: RMD) is a contender for most-discussed ASX stock over the past few weeks, as the healthcare share has lost one-third of its value since early August.

Red Leaf Securities chief John Athanasiou noted that the rise of new drugs like Ozempic is striking fear into investors.

"ResMed makes medical devices to treat sleep-disordered breathing.

"RedMed has been oversold on investor concerns that diabetes and obesity medicines will impact future sales of the company's sleep apnoea products."

However, both he and Bui reckon investors with long horizons need not worry.

"We believe these concerns are overblown," said Athanasiou.

"The cheaper share price provides an opportunity to invest in a blue chip company that offers long-term growth prospects."

Bui admitted one metric was weak in the August financial report, but the temptation to buy the dip is too great now.

"Margins were slightly softer than expected in the company's last quarterly results. From a long-term perspective, we see the recent pullback as an attractive entry point."

Motley Fool contributor Tony Yoo has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cheap Shares

A woman sits in a quiet home nook with her laptop computer and a notepad and pen on the table next to her as she smiles at information on the screen.
Cheap Shares

Is it time to buy these 2 beaten-up ASX shares in 2025?

I’m bullish about these two ASX shares that have gone through a sell-off.

Read more »

Two workers on site discuss the next stage of this civil engineering job, one points his hands upwards.
Cheap Shares

2 ASX 200 shares this fund manager thinks are trading at great value

These large industry players are good value.

Read more »

Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
Cheap Shares

2 ASX 200 shares with favourable risk-reward profiles

I think these two blue chips are worth a look right now.

Read more »

A man reacts with surprise when her see a bargain price on his phone.
Cheap Shares

3 cheap ASX 200 shares with big dividends to consider buying right now

These businesses offer impressive levels of passive income.

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Cheap Shares

3 beaten-down ASX 200 shares to consider buying before the next bull market

These shares could be cheap according to analysts. Here's why now they could be a buy.

Read more »

Some kids fly a kite in strong winds at sunset.
Cheap Shares

Childcare in focus this Federal Election: how much upside does Macquarie expect for G8 Education shares?

Here’s why a broker is bullish about this stock.

Read more »

Couple looking at their phone surprised, symbolising a bargain buy.
Cheap Shares

I think these 2 cheap ASX shares are buys for value investors

I like the price and potential of these businesses.

Read more »

Cheap Shares

3 oversold ASX shares begging to rebound

Analysts think these shares are too cheap to ignore at current levels.

Read more »